MBZUAI doctoral student Umaima Rahman is researching domain adaptation and generalization in deep learning for medical imaging to improve AI model performance across diverse hospitals and equipment. Her work focuses on building models that learn consistent features across different data sources to ensure reliability in various healthcare settings. Rahman emphasizes that generalization in healthcare AI is a necessity, especially in resource-limited settings, and aims to develop AI that assists clinicians rather than replaces them. Why it matters: This research addresses a critical challenge in deploying AI in healthcare, ensuring that models can be reliably used in diverse settings, particularly benefiting developing countries and improving global healthcare accessibility.
MBZUAI Associate Professor Mohammad Yaqub is focused on translating AI research into real-world healthcare solutions. His previous work includes the development of SanNav, an AI-based fetal anomaly detection system that became an FDA-approved product used by GE Healthcare and used on his own wife during pregnancy. Yaqub joined MBZUAI to help build a new model of AI research and education with a focus on interdisciplinary collaboration and industry partnerships. Why it matters: This highlights the UAE's growing focus on AI in healthcare and MBZUAI's role in bridging the gap between research and practical applications in the medical field.
MBZUAI is developing AI algorithms to intelligently process data from wearables and home sensors for remote patient monitoring. The algorithms aim to analyze multiple strands of health data to provide a more comprehensive view of a patient's health, distinguishing between genuine emergencies and benign situations. MBZUAI's provost, Professor Fakhri Karray, believes this approach could handle 20-25% of diagnoses virtually, reducing the burden on healthcare systems. Why it matters: This research could significantly improve healthcare efficiency and accessibility in the UAE and beyond by enabling more effective remote patient monitoring and reducing unnecessary hospital visits.
Sir Michael Brady, professor at Oxford and MBZUAI, argues that AI in healthcare must move beyond pattern recognition to causal understanding. He states that clinicians require AI models to articulate their reasoning behind diagnoses and therapy recommendations, not just provide statistical scores. He believes AI's immediate impact will be in personalized medicine, tailoring treatments to the individual rather than relying on epidemiological averages. Why it matters: This perspective highlights the critical need for explainable AI in sensitive domains like healthcare, paving the way for more trustworthy and clinically relevant AI applications in the region.
MBZUAI researchers are developing AI applications for malaria prevention in Indonesia using sensory data fusion and digital twins. Another MBZUAI team is using machine learning and computer vision to detect cardiovascular disease from CT scans in collaboration with the University of Oxford. AI-powered remote patient monitoring is also being explored for proactive interventions and chronic disease management. Why it matters: These projects demonstrate the potential of AI to address healthcare challenges in underserved communities and improve disease prevention and management in the region.